AustralianSuper Pty Ltd Trims Position in CVS Health Co. (NYSE:CVS)

AustralianSuper Pty Ltd lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 16.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,285,234 shares of the pharmacy operator’s stock after selling 252,557 shares during the period. AustralianSuper Pty Ltd’s holdings in CVS Health were worth $57,694,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. V Square Quantitative Management LLC raised its holdings in shares of CVS Health by 16.4% during the 4th quarter. V Square Quantitative Management LLC now owns 18,347 shares of the pharmacy operator’s stock worth $824,000 after acquiring an additional 2,586 shares during the period. Root Financial Partners LLC purchased a new position in shares of CVS Health during the 4th quarter worth $248,000. MidAtlantic Capital Management Inc. raised its holdings in shares of CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator’s stock worth $37,000 after acquiring an additional 437 shares during the period. Aljian Capital Management LLC raised its holdings in shares of CVS Health by 21.0% during the 4th quarter. Aljian Capital Management LLC now owns 13,349 shares of the pharmacy operator’s stock worth $599,000 after acquiring an additional 2,319 shares during the period. Finally, Stanley Laman Group Ltd. increased its position in shares of CVS Health by 1,366.8% during the 4th quarter. Stanley Laman Group Ltd. now owns 80,672 shares of the pharmacy operator’s stock worth $3,621,000 after purchasing an additional 75,172 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $65.71 on Friday. The stock has a 50-day simple moving average of $50.90 and a 200-day simple moving average of $56.01. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market capitalization of $82.68 billion, a PE ratio of 16.68, a PEG ratio of 0.60 and a beta of 0.61. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. On average, analysts predict that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Analyst Ratings Changes

A number of analysts recently issued reports on CVS shares. Wolfe Research raised their price objective on CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research report on Tuesday. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Truist Financial raised their price objective on CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Mizuho cut their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $70.28.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.